| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | TCN 201 |
|---|
| Description | NMDA receptor antagonist selective for GluN1/GluN2A (formally NR1/NR2A) over GluN1/GluN2B (formally NR1/NR2B) containing receptors (pIC50 values are 6.8 and <4.3, respectively, in human recombinant GluN1/GluN2A (formally NR1/NR2A) and GluN1/GluN2B (formally NR1/NR2B) FLIPR/Ca2+ assays). Please refer to IUPHAR Guide to Pharmacology for the most recent naming conventions. Purity 99%. MW (observed): 461.89 |
|---|
| Size | 10 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 3-Chloro-4-fluoro-N-[4-[[2-(phenylcarbonyl)hydrazino]carbonyl]benzyl]benzenesulfonamide |
|---|
| Gene, Accession, CAS # | CAS: 852918-02-6 |
|---|
| Catalog # | 4154/10 |
|---|
| Price | |
|---|
| Order / More Info | TCN 201 from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | PubMed: 24121738, 25413830, 25800054, 25858512, 26282667, 27001011, 27538456, 27807032, 27857196 |
|---|
| 產(chǎn)品資料 |
|
|